(Aluminum chloride)
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Antidral contains aluminum chloride, which reduces the activity of sweat glands by denaturing proteins contained in the glands and binding to fibrous fibers, which are the endings of external secretion glands. After applying the liquid, the pressure inside the sweat duct increases (feedback system), resulting in the inhibition of sweat secretion from the sweat glands. The other ingredients of the medicine facilitate the absorption of the active substance and significantly reduce the possibility of skin infections. Antidral is used externally on excessively sweating skin surfaces, i.e. on the skin of the feet, armpits, and hands. Antidral eliminates or alleviates unpleasant symptoms associated with excessive sweating.
The use of the medicine should be limited to the skin surfaces for which the liquid is indicated. Contact between the Antidral liquid and the mucous membrane and eyes should be avoided.
No data available. The doctor should be informed about all medicines taken recently, including those available without a prescription.
Not applicable.
No data on the use of the liquid in children. Before using the medicine, a doctor should be consulted.
Not applicable.
Before using any medicine, a doctor or pharmacist should be consulted.
Antidral has no effect on the ability to drive vehicles and operate machinery.
Antidral contains ethanol (96%). This medicine contains 500 mg of alcohol (ethanol) per gram of liquid. Antidral may cause burning of damaged skin. In newborns (premature and full-term infants), high concentrations of ethanol may cause severe local and systemic toxicity due to significant absorption through immature skin (especially under occlusive dressings).
The liquid is used externally. Antidral should be used daily at night (when the activity of the sweat glands is lower), after thoroughly washing and drying the skin (avoid rubbing). In cases of less intense sweating, it is recommended to use the liquid every other or every third day, depending on the individual needs of the patient. This medicine should always be used in accordance with the description in the patient leaflet. In case of doubts, a doctor or pharmacist should be consulted.
In case of overdose, skin irritation may occur. If skin irritation occurs, the use of Antidral should be discontinued. Irritated areas should be smeared with a mild hydrocortisone cream. Antidral can be used again after the complete disappearance of irritation symptoms. Overdose is treated symptomatically. In case of any further doubts related to the use of this medicine, a doctor or pharmacist should be consulted.
Like all medicines, this medicine may cause side effects, although they may not occur in everyone. During the use of the liquid, symptoms of skin irritation, such as burning, itching, or redness, may occur. In such cases, treatment should be discontinued. In some people, other side effects may occur during the use of Antidral. If other side effects occur that are not listed in this leaflet, the doctor should be informed. Reporting side effects If any side effects occur, including any not listed in the leaflet, the doctor, pharmacist, or nurse should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products Al. Jerozolimskie 181 C, 02-222 Warsaw Tel: +48 22 49 21 301 Fax: +48 22 49 21 309 Website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be collected on the safety of the medicine.
Store at a temperature below 25°C. Store in a place out of sight and reach of children. Store in an upright position, in a tightly closed packaging. Do not use this medicine after the expiry date stated on the bottle and carton. The expiry date refers to the last day of the specified month. Medicines should not be disposed of via wastewater or household waste containers. A pharmacist should be asked how to dispose of medicines that are no longer used. This will help protect the environment.
The active substance is aluminum chloride (1 gram of liquid contains 100 mg of aluminum chloride). The other excipients are: glycerol, ethanol, purified water, hydroxyethyl cellulose.
HDPE polyethylene bottle, GGNX-18-D003 type polyethylene cap, gray polypropylene cap in a cardboard box. 1 bottle contains 50 ml of liquid.
Teva Pharmaceuticals Polska Sp. z o.o. ul. Emilii Plater 53 00-113 Warsaw Tel: (22) 345 93 00
Nobilus Ent ul. Zegrzyńska 22A 05-110 Jabłonna Poland
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.